Corneal Epithelial Stem Cells and Dry Eye Disease

Completed · Not applicable

Conditions studied: Dry Eye Syndromes, Dry Eye, Ocular Inflammation, Ocular Surface Disease, Ocular Discomfort, Blepharitis

In brief

To study of a novel, therapeutic Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) in the treatment of severe dry eye disease that is failing conventional treatments. This pilot study will carefully observe and monitor each qualifying and willing individual for response to treatment, signs of toxicity and adverse effects from the treatment, and for ability of the treatment to improve comfort and restore vision.

Key facts

Study ID

NCT03302273

Run by

Sloan W. Rush, MD

People needed

17

Starts

2019-02-01

Expected to finish

2022-04-01

Last updated by the study team

2022-04-21

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of advanced dry eye disease
• Severe dry eye symptoms despite having tried over a half dozen treatments

You may not qualify if…

• Not willing to undergo clinical trial
• Unable to comply with treatment regimen

Where it is running

• Rush Eye Associates — Amarillo, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.